13F-HR filed by Vantage Consulting Group Inc
Vantage Consulting Group Inc filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 4 holding rows worth $11,416,309.
- Accession
- 0001172661-24-004815
- Filer
- CIK 1843547
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 4 entries on the cover page, a total value of $11,416,309 stated on the cover page (in dollars after the unit check, H1), rows summing to $11,416,309 with VALUE read as dollars as filed, 13F file number 028-20786. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BABCOCK & WILCOX ENTERPRISES | 05614L209 | COM | 2,416,200 | $4,929,048 | dollars as filed | |
| CIBUS INC | 17166A101 | CL A COM STK | 1,143,949 | $3,729,274 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 850,737 | $2,679,822 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 195,707 | $78,165 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-004815 | this filing | 2024-11-14 | acceptance time not in the bulk data set |